AXT-120

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAXT-120
Drug Alias Namebiomimetic peptide (Johns Hopkins University School of Medicine/AsclepiX Therapeutics)AXT-120
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeovascularization, Pathologic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University School Of MedicineAsclepiX Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeovascularization, Pathologic

Other Information

ATC CodeN/A
Related LinksN/A